| Bioactivity | GS-621763, an orally bioavailable prodrug of GS-441524, shows antiviral activity against SARS-CoV-2 pathogenesis in mice. |
| Name | GS-621763 |
| CAS | 2647442-13-3 |
| Formula | C24H31N5O7 |
| Molar Mass | 501.53 |
| Appearance | Solid |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | 4°C, sealed storage, away from moisture and light *In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light) |
| Reference | [1]. Schäfer A, et al. Therapeutic efficacy of an oral nucleoside analog of remdesivir against SARS-CoV-2 pathogenesis in mice. bioRxiv [Preprint]. 2021 Sep 17:2021.09.13.460111. |
GS-621763
CAS: 2647442-13-3 F: C24H31N5O7 W: 501.53
GS-621763, an orally bioavailable prodrug of GS-441524, shows antiviral activity against SARS-CoV-2 pathogenesis in mice
Data collection：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.